EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.5.3.15 | Acute Kidney Injury |
29021225 |
ATP induces PAD4 in renal proximal tubule cells via P2X7 receptor activation to exacerbate ischemic AKI. |
causal interaction
unassigned |
3
0 |
| 3.5.3.15 | Acute Kidney Injury |
29357426 |
Divergent roles for kidney proximal tubule and granulocyte PAD4 in ischemic AKI. |
causal interaction
ongoing research
unassigned |
1
4
0 |
| 3.5.3.15 | Acute Kidney Injury |
33295402 |
Evaluation of peptidylarginine deiminase 4 and PADI4 polymorphisms in sepsis-induced acute kidney injury. |
causal interaction
diagnostic usage
ongoing research
unassigned |
3
4
2
0 |
| 3.5.3.15 | Adenocarcinoma |
19183436 |
Increased PADI4 expression in blood and tissues of patients with malignant tumors. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
4
2 |
| 3.5.3.15 | Adenocarcinoma |
20827398 |
Expression of peptidylarginine deiminase type 4 in ovarian tumors. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
3
4
4 |
| 3.5.3.15 | Adenocarcinoma |
21698003 |
Investigating the pathogenic role of PADI4 in oesophageal cancer. |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
3
3
0 |
| 3.5.3.15 | Adenocarcinoma |
31428515 |
DNA released from neutrophil extracellular traps (NETs) activates pancreatic stellate cells and enhances pancreatic tumor growth. |
causal interaction
therapeutic application
unassigned |
4
4
0 |
| 3.5.3.15 | Adenocarcinoma |
32629995 |
Putative Roles for Peptidylarginine Deiminases in COVID-19. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
3
2
0 |
| 3.5.3.15 | Adenocarcinoma |
34295566 |
PADI1 contributes to EMT in PAAD by activating the ERK1/2-p38 signaling pathway. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
2
3
3 |
| 3.5.3.15 | Adenocarcinoma of Lung |
19183436 |
Increased PADI4 expression in blood and tissues of patients with malignant tumors. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
4
2 |
